5-BROMO-4-(5-BROMO-4-CHLORO-2-THIENYL)-2-THIAZOLAMINE
UNII Q22S6KS3JQ

Substance Identification & Data

This profile provides standardized clinical and technical data for 5-bromo-4-(5-bromo-4-chloro-2-thienyl)-2-thiazolamine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q22S6KS3JQ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2401867-89-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q22S6KS3JQ

CAS Registry Number

2401867-89-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

5-BROMO-4-(5-BROMO-4-CHLORO-2-THIENYL)-2-THIAZOLAMINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C7H3Br2ClN2S2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AULWXGLYZIDHCH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

149707755

Unique identification number in the NCBI database of chemical substances.

Substance Type

5-Bromo-4-(5-bromo-4-chloro-2-thienyl)-2-thiazolamine

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Nc1nc(-c2cc(Cl)c(Br)s2)c(Br)s1

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 5-bromo-4-(5-bromo-4-chloro-2-thienyl)-2-thiazolamine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.